TECX
Tectonic Therapeutic Inc.
$18.25
+$0.65(+3.69%)
61
Overall
60
Value
75
Tech
50
Quality
Market Cap
$334.57M
Volume
919.74K
52W Range
$13.70 - $61.07
Target Price
$79.75
Order:
Income Statement
| Metric | Trend | Chart | 2018 Dec | 2019 Dec | 2020 Dec | 2021 Dec | 2022 Dec | 2023 Dec | 2024 Dec |
|---|---|---|---|---|---|---|---|---|---|
| REVENUE | |||||||||
| Total Revenue | -- | -- | -- | -- | $23.0K | $77.0K | -- | ||
| Total Revenue | -- | -- | -- | -- | $23.0K | $77.0K | -- | ||
| COST OF GOODS SOLD | |||||||||
| Cost of Revenue | -- | -- | -- | -- | $3.0M | -- | -- | ||
| GROSS PROFIT | |||||||||
| Gross Profit | -- | -- | -- | -- | $-2.9M | $-2.0M | -- | ||
| OPERATING EXPENSES | |||||||||
| Operating Expenses | $-46.2M | $75.8M | $120.2M | $118.8M | $105.4M | $44.6M | $58.0M | ||
| Research & Development | $35.1M | $55.0M | $87.2M | $83.1M | $72.2M | $37.0M | $41.4M | ||
| Research Expense | $35.1M | $55.0M | $87.2M | $83.1M | $72.2M | $37.0M | $41.4M | ||
| Selling, General & Administrative | $11.1M | $20.8M | $33.0M | $35.7M | $33.2M | $7.7M | $16.7M | ||
| General & Administrative Expenses | $11.1M | $20.8M | $33.0M | $35.7M | $33.2M | $7.7M | $16.7M | ||
| Salaries & Wages | $-2.2M | $-6.8M | -- | -- | -- | $1.1M | $3.5M | ||
| Depreciation & Amortization | $-380.0K | $-850.0K | $1.2M | $1.4M | $1.4M | $1.5M | $1.6M | ||
| Depreciation & Amortization | $-380.0K | $-850.0K | $1.2M | $1.4M | $1.4M | $1.5M | $1.6M | ||
| Amortization | -- | -- | -- | -- | -- | $488.0K | $448.0K | ||
| Other Operating Expenses | -- | -- | -- | -- | $3.0M | $44.6M | $58.0M | ||
| OPERATING INCOME | |||||||||
| Operating income | $-46.2M | $-75.8M | $-120.2M | $-118.8M | $-105.4M | $-44.6M | $-58.0M | ||
| EBITDA | $-45.9M | $-72.1M | $-119.0M | $-117.4M | $-104.0M | $-55.7M | $-73.2M | ||
| NON-OPERATING ITEMS | |||||||||
| Interest Expense (Non-Operating) | -- | -- | -- | $203.0K | $1.8M | $151.0K | $107.0K | ||
| Intinc | $1.7M | $2.9M | $719.0K | -- | -- | $581.0K | $4.3M | ||
| Net Non-Operating Interest Income/Expense | $1.7M | $2.9M | $719.0K | $-203.0K | $299.0K | $581.0K | $4.3M | ||
| Gain on Sale of Securities | $-1.6M | -- | $719.0K | $-224.0K | $-299.0K | $2.4M | -- | ||
| Other Income/Expense | $1.8M | $90.0K | $-516.0K | $285.0K | $-157.0K | $-396.0K | $511.0K | ||
| Other Special Charges | $-215.0K | $-90.0K | $-203.0K | $-61.0K | $-157.0K | $396.0K | $-511.0K | ||
| SPECIAL ITEMS | |||||||||
| Restructring And Mn A Income | -- | -- | -- | -- | -- | $5.1M | -- | ||
| Special Income Charges | -- | -- | -- | -- | -- | $-6.0M | -- | ||
| Impairment of Capital Assets | -- | -- | -- | -- | -- | $940.0K | -- | ||
| PRE-TAX INCOME | |||||||||
| EBIT | $-46.4M | $-73.0M | $-120.2M | $-118.8M | $-105.4M | $-57.2M | $-74.8M | ||
| Pre-Tax Income | $-46.4M | $-73.0M | $-119.7M | $-119.1M | $-105.9M | $-43.7M | $-54.3M | ||
| INCOME TAX | |||||||||
| Tax Provision | -- | -- | -- | -- | -- | $-14.6M | $-16.9M | ||
| NET INCOME | |||||||||
| Net Income | $-46.4M | $-73.0M | $-119.7M | $-119.1M | $-105.9M | $-42.8M | $-58.0M | ||
| Net Income (Continuing Operations) | $-46.4M | $-73.0M | $-119.7M | $-119.1M | $-105.9M | $-42.8M | $-58.0M | ||
| Net Income (Discontinued Operations) | $-46.4M | $-73.0M | $-119.7M | $-119.1M | $-105.9M | $-42.8M | $-58.0M | ||
| Net Income (Common Stockholders) | $-48.6M | $-73.0M | $-119.7M | $-119.1M | $-105.9M | $-42.8M | $-58.0M | ||
| Normalized Income | -- | -- | -- | -- | -- | -- | $-71.2M | ||
| TOTALS | |||||||||
| Total Expenses | $-46.2M | $75.8M | $120.2M | $118.8M | $105.4M | $44.6M | $58.0M | ||
| SHARE & EPS DATA | |||||||||
| Average Shares Outstanding | $1.1M | $27.4M | $36.2M | $42.9M | $43.7K | $3.7M | $8.5M | ||
| Average Shares Outstanding (Diluted) | $1.1M | $27.4M | $36.2M | $42.9M | $43.7K | $3.7M | $8.5M | ||
| Shares Outstanding | $2.0M | $36.0M | $41.6M | $43.7M | $18.7M | $3.7M | $18.7M | ||
| Basic EPS | -- | -- | $-3.31 | $-2.78 | $-2.42 | $3.24 | $-6.83 | ||
| Basic EPS (Continuing Operations) | -- | -- | $-3.31 | $-2.78 | $-2.42 | $3.24 | $-6.83 | ||
| Diluted EPS | $-43.44 | $-2.66 | $-3.31 | $-2.78 | $-2.42 | $3.24 | $-6.83 | ||
| Diluted EPS (Continuing Operations) | -- | $-2.66 | -- | -- | $-2.42 | $3.24 | $-6.83 | ||
| OTHER METRICS | |||||||||
| Accretion On Preferred Stock | $2.2M | -- | -- | -- | -- | -- | -- | ||
| Gain On Sale Of P P E | -- | -- | -- | -- | -- | $83.7M | -- | ||
| Other Gand A | $11.1M | $20.8M | $33.0M | $35.7M | $33.2M | $7.7M | $16.7M | ||
| Other Impairment Of Capital Assets | $-235.0K | -- | -- | -- | -- | $-937.0K | -- | ||
| Otherunder Preferred Stock Dividend | $2.2M | -- | -- | -- | -- | -- | -- | ||
| Preferred Stock Dividends | $2.2M | -- | -- | -- | -- | -- | -- | ||
| Rent And Landing Fees | $11.1M | $-2.3M | $2.4M | $2.6M | $3.2K | -- | -- | ||
| Restruct | -- | -- | -- | -- | -- | $5.1M | -- | ||
Financial data is updated quarterly and may not reflect the most recent earnings.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TECX | $18.25 | +3.7% | 919.74K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Tectonic Therapeutic Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW